CANT

Olivia Brayer

Q: How accurate are Olivia Brayer's stock ratings?

About 54% of Olivia's ratings were profitable over a one-year hold, with an average return of +10.0% per rating, measured by 13Foresight from historical prices.

Q: How is Olivia ranked?

Olivia Brayer is ranked #2146 on 13Foresight, scored on hit rate, average return versus the market, and number of calls.

Cantor Fitzgerald

Wall Street Analyst

★★★☆☆

#2146

on 13Foresight · ranked by our own returns

54%

Success Rate

+10.0%

Average Return

15 of 28 calls profitable · -2.9% vs benchmark

Time Frame ⓘ

1 Yr 2 Yr 3 Yr 5 Yr

Compared To ⓘ

S&P 500 (SPY)

📈 Across the calls we could measure, roughly 54% of Olivia Brayer's ratings turned a profit when each position was held for 1 year — averaging +10.0% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

33 Buy 3 Hold 0 Sell

Olivia's Stock Coverage 22 ratings · 2026-08-12

Company	Date	Position	Consensus ⓘ	Price Target ⓘ	1-Yr Return	vs S&P 500 ⓘ
VNDA Vanda	Aug 06, 2026	BUY	Strong Buy +304.9% avg upside 13 analysts	$11.00 123.12% Upside	+0.0%	·
INSM Insmed	Aug 06, 2026	BUY	Strong Buy +33.2% avg upside 37 analysts	$235.00 77.29% Upside	+0.3%	·
MNKD MannKind	Aug 05, 2026	BUY	Buy +82.2% avg upside 22 analysts	$8.00 108.36% Upside	-4.6%	·
TENX Tenax Therapeutics	Jul 29, 2026	BUY	Strong Buy +1504.9% avg upside 9 analysts	$35.00 2060.55% Upside	-11.9%	·
QNCX Quince Therapeutics	Jun 25, 2026	BUY	Buy +564.2% avg upside 16 analysts	$80.00 144.34% Upside	·	·
CNTB Connect Biopharma Holdings	May 21, 2026	BUY	Strong Buy +196.0% avg upside 12 analysts	$4.00 78.66% Upside	-6.6%	·
IKT Inhibikase Therapeutics	May 18, 2026	BUY	Strong Buy +143.8% avg upside 8 analysts	$4.00 63.33% Upside	+49.1%	·
PTHS Pelthos Therapeutics	Apr 01, 2026	BUY	Strong Buy +97.9% avg upside 8 analysts	$50.00 74.56% Upside	+36.1%	·
GOSS Gossamer Bio	Mar 20, 2026	HOLD	Buy +3647.8% avg upside 17 analysts	—	-56.7%	·
CTMX CytomX Therapeutics	Mar 20, 2026	BUY	Strong Buy +214.5% avg upside 21 analysts	$12.00 247.81% Upside	-22.7%	·
UTHR United Therapeutics	Mar 12, 2026	BUY	Buy -16.7% avg upside 26 analysts	$625.00 21.29% Upside	-4.0%	·
BMRN BioMarin Pharmaceutical	Mar 02, 2026	BUY	Strong Buy +36.7% avg upside 52 analysts	$85.00 22.28% Upside	+17.5%	·
ALNY Alnylam Pharma	Feb 12, 2026	HOLD	Strong Buy +46.8% avg upside 51 analysts	$400.00 80.87% Upside	-27.6%	·
VRTX Vertex Pharmaceuticals	Feb 11, 2025	BUY	Strong Buy -15.5% avg upside 62 analysts	$480.00 9.37% Downside	+1.3%	·
AMGN Amgen	Feb 05, 2025	BUY	Buy -23.9% avg upside 57 analysts	$340.00 17.96% Downside	+23.4%	·
BMY Bristol-Myers Squibb	Feb 04, 2025	HOLD	Buy -4.4% avg upside 42 analysts	$55.00 13.44% Downside	+2.4%	·
GILD Gilead Sciences	Nov 06, 2024	HOLD	Strong Buy -12.1% avg upside 66 analysts	$80.00 41.13% Downside	+38.6%	·
REGN Regeneron	Apr 17, 2024	HOLD	Strong Buy -2.1% avg upside 58 analysts	$925.00 16.06% Upside	-37.4%	·
AUPH Aurinia Pharmaceuticals	Feb 23, 2024	BUY	Strong Buy -0.4% avg upside 12 analysts	$10.00 35.00% Downside	+33.3%	·
OMER Omeros	Nov 10, 2023	HOLD	Buy +54.9% avg upside 14 analysts	—	+252.8%	·
CRSP Crispr Therapeutics AG	Oct 17, 2023	HOLD	Buy +40.2% avg upside 41 analysts	—	+10.6%	·
LENZ LENZ Therapeutics	Mar 20, 2023	HOLD	Buy +352.6% avg upside 17 analysts	$3.00 42.43% Downside	+91.1%	·

🔒 17 more ratings — with price targets, crowd consensus and our measured returns.

Free account unlocks every analyst's full coverage table.

Olivia Brayer — Frequently Asked Questions

How accurate are Olivia Brayer's stock ratings?

Based on the calls 13Foresight could measure, about 54% of Olivia's ratings were profitable over a one-year hold, with an average return of +10.0% per rating, or -2.9% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.

How is Olivia ranked on 13Foresight?

Olivia Brayer is currently ranked #2146 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.

Which stocks does Olivia cover?

Olivia most recently has ratings on VNDA, INSM, MNKD, TENX, QNCX, CNTB, IKT, PTHS, GOSS, CTMX, UTHR, BMRN and 10 more. See the full coverage table above for positions, price targets and our measured returns.

Where can I see other analyst ratings?

Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.

Olivia Brayer

Rating Distribution

Welcome to 13Foresight!